Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Biologics : Targets & Therapy|August 27, 2009
Novel microtubule-targeting agents - the epothilonesKit L Cheng, Thomas Bradley, Daniel R BudmanCurrent Treatment Options in Oncology|April 11, 2009
Adjuvant chemotherapy for early breast cancer in the elderlyMary Leung, Iulianna Shapira, Thomas Bradley, et al.Oncology|February 28, 2009
Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature reviewBrian H Kim, Thomas Bradley, Julia Tai, et al.Seminars in Oncology|February 24, 2005
Dose and schedule as determinants of outcomes in chemotherapy for breast cancerDaniel R BudmanOncology (Williston Park, N.Y.)|November 19, 2002
New directions with capecitabine combinations in advanced breast cancerDaniel R BudmanClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 4, 2008
Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcomeMyra F Barginear, Martin Lesser, Meredith Lukin Akerman, et al.Oncology|April 29, 2006
Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agentsDaniel R Budman, Anthony CalabroBreast Cancer Research and Treatment|August 2, 2002
In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell linesDaniel R Budman, Anthony CalabroCancer Investigation|June 14, 2005
Review: tubulin function, action of antitubulin drugs, and new drug developmentFederico Pellegrini, Daniel R BudmanAnti-Cancer Drugs|October 1, 2004
Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111Daniel R Budman, Anthony CalabroPageof 8